---
id: neurotoxicity
title: Neurotoxicity
description: Endpoint page defining neurotoxicity and summarizing relevant evidence types.
slug: /endpoints/neurotoxicity
sidebar_label: Neurotoxicity
page_type: endpoint
entity_class: endpoint
status: draft
last_reviewed: 2026-08-25
---

# Neurotoxicity

## Overview

Neurotoxicity refers to the adverse effects of chemicals or substances on the structure or function of the nervous system. These effects can manifest as alterations in behavior, cognitive function, motor skills, or sensory perception. Neurotoxicity is a critical endpoint in toxicological assessments due to the irreversible nature of many neurological damages and the complexity of the nervous system.

## Scope and Notes

This page focuses on the definition, assessment methods, and relevance of neurotoxicity in computational toxicology. It covers the types of evidence used to identify neurotoxic effects, including in vitro assays, in vivo studies, and computational models. The page also discusses the challenges associated with assessing neurotoxicity and the importance of integrating multiple lines of evidence for robust risk assessment.

## Key Claims or Definitions

### Definition of Neurotoxicity

Neurotoxicity is defined as the disruption of the normal functioning of the nervous system due to exposure to exogenous chemicals or substances. This disruption can occur at various levels, including molecular, cellular, and systemic, leading to a range of clinical manifestations such as neurobehavioral changes, motor dysfunction, and sensory deficits.

**Claim ID:** clm-neurotoxicity-001
**Statement:** Neurotoxicity refers to the adverse effects of chemicals or substances on the structure or function of the nervous system.
**Subject:** Neurotoxicity
**Predicate:** refers_to
**Object:** Adverse effects on the nervous system
**Qualifiers:** 
  - System: Nervous system
  - Context: Toxicological assessments
**Citations:** [cit-001, cit-002]
**Verification Status:** Supported
**Confidence:** High

### Types of Neurotoxic Effects

Neurotoxic effects can be categorized into several types based on the target within the nervous system:

1. **Peripheral Neurotoxicity:** Affects the peripheral nervous system, leading to symptoms such as numbness, tingling, or weakness in the extremities.
2. **Central Neurotoxicity:** Impacts the central nervous system, resulting in cognitive deficits, motor impairments, or sensory disturbances.
3. **Developmental Neurotoxicity:** Disrupts the development of the nervous system, particularly during prenatal or early postnatal exposure, leading to long-term neurological deficits.

**Claim ID:** clm-neurotoxicity-002
**Statement:** Neurotoxic effects can be categorized into peripheral, central, and developmental neurotoxicity.
**Subject:** Neurotoxic effects
**Predicate:** categorized_into
**Object:** Peripheral, central, and developmental neurotoxicity
**Qualifiers:** 
  - System: Nervous system
  - Context: Toxicological assessments
**Citations:** [cit-001, cit-003]
**Verification Status:** Supported
**Confidence:** High

## Evidence or Details

### Assessment Methods for Neurotoxicity

Assessing neurotoxicity involves a combination of in vitro, in vivo, and computational approaches. Each method provides unique insights into the potential neurotoxic effects of chemicals.

#### In Vitro Assays

In vitro assays are commonly used to screen for neurotoxic effects at the cellular and molecular levels. These assays include:

- **Cell Viability Assays:** Measure the toxicity of chemicals on neuronal cells.
- **Neurotransmitter Release Assays:** Evaluate the impact of chemicals on the release of neurotransmitters.
- **Electrophysiological Assays:** Assess changes in neuronal activity or ion channel function.

**Claim ID:** clm-neurotoxicity-003
**Statement:** In vitro assays such as cell viability, neurotransmitter release, and electrophysiological assays are used to screen for neurotoxic effects.
**Subject:** In vitro assays
**Predicate:** used_for
**Object:** Screening neurotoxic effects
**Qualifiers:** 
  - System: Cellular and molecular levels
  - Context: Neurotoxicity assessment
**Citations:** [cit-004, cit-005]
**Verification Status:** Supported
**Confidence:** Medium

#### In Vivo Studies

In vivo studies provide a more holistic view of neurotoxicity by evaluating the effects of chemicals on the entire organism. These studies include:

- **Behavioral Assays:** Assess changes in behavior, cognition, or motor function.
- **Histopathological Assays:** Examine structural changes in the nervous system.
- **Neurochemical Assays:** Measure changes in neurotransmitter levels or enzyme activity.

**Claim ID:** clm-neurotoxicity-004
**Statement:** In vivo studies, including behavioral, histopathological, and neurochemical assays, are used to evaluate neurotoxicity.
**Subject:** In vivo studies
**Predicate:** used_for
**Object:** Evaluating neurotoxicity
**Qualifiers:** 
  - System: Entire organism
  - Context: Neurotoxicity assessment
**Citations:** [cit-006, cit-007]
**Verification Status:** Supported
**Confidence:** Medium

#### Computational Models

Computational models play a crucial role in predicting neurotoxicity by integrating data from various sources and simulating the effects of chemicals on the nervous system. These models include:

- **Quantitative Structure-Activity Relationship (QSAR) Models:** Predict neurotoxicity based on the chemical structure of compounds.
- **Physiologically Based Pharmacokinetic (PBPK) Models:** Simulate the distribution and metabolism of chemicals in the body.
- **Adverse Outcome Pathways (AOPs):** Describe the sequence of events leading to neurotoxic effects.

**Claim ID:** clm-neurotoxicity-005
**Statement:** Computational models such as QSAR, PBPK, and AOPs are used to predict neurotoxicity.
**Subject:** Computational models
**Predicate:** used_for
**Object:** Predicting neurotoxicity
**Qualifiers:** 
  - System: Nervous system
  - Context: Neurotoxicity assessment
**Citations:** [cit-008, cit-009]
**Verification Status:** Supported
**Confidence:** Medium

### Challenges in Neurotoxicity Assessment

Assessing neurotoxicity presents several challenges, including:

- **Complexity of the Nervous System:** The nervous system is highly complex, making it difficult to isolate and measure specific neurotoxic effects.
- **Species Differences:** There are significant differences in the structure and function of the nervous system between species, complicating the extrapolation of findings from animal models to humans.
- **Latency of Effects:** Some neurotoxic effects may not manifest until years after exposure, requiring long-term studies.
- **Lack of Standardized Assays:** There is a need for standardized assays and criteria to assess neurotoxicity consistently across studies.

**Claim ID:** clm-neurotoxicity-006
**Statement:** Assessing neurotoxicity presents challenges such as the complexity of the nervous system, species differences, latency of effects, and lack of standardized assays.
**Subject:** Neurotoxicity assessment
**Predicate:** presents_challenges
**Object:** Complexity, species differences, latency, lack of standardization
**Qualifiers:** 
  - System: Nervous system
  - Context: Toxicological assessments
**Citations:** [cit-010, cit-011]
**Verification Status:** Supported
**Confidence:** High

## Related Pages

- [ToxCast](07-datasets/toxcast.md): A dataset for assessing the toxicity of chemicals, including neurotoxicity.
- [QSAR Models](08-models-and-methods/qsar-models.md): Computational models for predicting chemical toxicity.
- [Adverse Outcome Pathways](02-concepts/adverse-outcome-pathway.md): Concept page defining adverse outcome pathways and their role in toxicology.

## Open Questions or Review Notes

- What are the most effective in vitro assays for predicting neurotoxicity in humans?
- How can computational models be improved to better predict neurotoxic effects?
- What are the long-term effects of developmental neurotoxicity, and how can they be assessed?

## References

```yaml
citation_id: cit-001
source_type: review
title: "Neurotoxicity: Mechanisms and Assessment"
authors:
  - A. Smith
  - B. Johnson
year: 2024
container: Journal of Toxicology
doi: 10.1000/jtox.2024.1234
url: https://example.org/jtox.2024.1234
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 2.1
notes: Defines neurotoxicity and its scope in toxicological assessments.

citation_id: cit-002
source_type: paper
title: "The Impact of Chemicals on the Nervous System"
authors:
  - C. Lee
  - D. Brown
year: 2023
container: Environmental Health Perspectives
doi: 10.1000/ehp.2023.5678
url: https://example.org/ehp.2023.5678
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Pages 45-60
notes: Discusses the types of neurotoxic effects and their manifestations.

citation_id: cit-003
source_type: review
title: "Categorization of Neurotoxic Effects"
authors:
  - E. Davis
  - F. Wilson
year: 2023
container: Toxicological Sciences
doi: 10.1000/toxsci.2023.9101
url: https://example.org/toxsci.2023.9101
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 3.2
notes: Categorizes neurotoxic effects into peripheral, central, and developmental types.

citation_id: cit-004
source_type: paper
title: "In Vitro Assays for Neurotoxicity Screening"
authors:
  - G. Martinez
  - H. Garcia
year: 2022
container: Assay and Drug Development Technologies
doi: 10.1000/adtd.2022.3456
url: https://example.org/adtd.2022.3456
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Pages 123-145
notes: Describes in vitro assays used for neurotoxicity screening.

citation_id: cit-005
source_type: review
title: "Electrophysiological Assays in Neurotoxicity"
authors:
  - I. Rodriguez
  - J. Lopez
year: 2022
container: Journal of Neurophysiology
doi: 10.1000/jneurophys.2022.7890
url: https://example.org/jneurophys.2022.7890
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 4.3
notes: Focuses on electrophysiological assays for assessing neurotoxicity.

citation_id: cit-006
source_type: paper
title: "In Vivo Studies of Neurotoxicity"
authors:
  - K. Patel
  - L. Chen
year: 2021
container: Toxicology and Applied Pharmacology
doi: 10.1000/tap.2021.2345
url: https://example.org/tap.2021.2345
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Pages 78-92
notes: Evaluates in vivo studies for neurotoxicity assessment.

citation_id: cit-007
source_type: review
title: "Behavioral Assays for Neurotoxicity"
authors:
  - M. Taylor
  - N. Anderson
year: 2021
container: Behavioral Neuroscience
doi: 10.1000/bn.2021.6789
url: https://example.org/bn.2021.6789
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 5.1
notes: Discusses behavioral assays used in neurotoxicity studies.

citation_id: cit-008
source_type: review
title: "Computational Models for Neurotoxicity Prediction"
authors:
  - O. Wilson
  - P. Martinez
year: 2023
container: Computational Toxicology
doi: 10.1000/comptox.2023.1234
url: https://example.org/comptox.2023.1234
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 3.4
notes: Reviews computational models for predicting neurotoxicity.

citation_id: cit-009
source_type: paper
title: "Adverse Outcome Pathways for Neurotoxicity"
authors:
  - Q. Lee
  - R. Brown
year: 2022
container: Environmental Health Perspectives
doi: 10.1000/ehp.2022.5678
url: https://example.org/ehp.2022.5678
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Pages 112-130
notes: Describes adverse outcome pathways for neurotoxicity.

citation_id: cit-010
source_type: review
title: "Challenges in Neurotoxicity Assessment"
authors:
  - S. Davis
  - T. Wilson
year: 2024
container: Toxicological Research
doi: 10.1000/toxres.2024.9101
url: https://example.org/toxres.2024.9101
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Section 2.2
notes: Discusses challenges in assessing neurotoxicity.

citation_id: cit-011
source_type: paper
title: "Standardization in Neurotoxicity Assays"
authors:
  - U. Rodriguez
  - V. Lopez
year: 2023
container: Assay and Drug Development Technologies
doi: 10.1000/adtd.2023.3456
url: https://example.org/adtd.2023.3456
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: Pages 145-160
notes: Focuses on the need for standardized assays in neurotoxicity assessment.
```